SANOFI (SNW.DE) Stock Fundamental Analysis

FRA:SNW • FR0000120578

77.74 EUR
+0.39 (+0.5%)
Last: Feb 18, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

Taking everything into account, SNW scores 5 out of 10 in our fundamental rating. SNW was compared to 52 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of SNW while its profitability can be described as average. SNW has a correct valuation and a medium growth rate. Finally SNW also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • SNW had positive earnings in the past year.
  • In the past 5 years SNW has always been profitable.
  • SNW had a positive operating cash flow in each of the past 5 years.
SNW.DE Yearly Net Income VS EBIT VS OCF VS FCFSNW.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 10.63%, SNW is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • The Return On Equity of SNW (18.84%) is better than 63.46% of its industry peers.
  • SNW has a better Return On Invested Capital (13.35%) than 63.46% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for SNW is significantly below the industry average of 14.45%.
  • The last Return On Invested Capital (13.35%) for SNW is above the 3 year average (7.41%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROIC 13.35%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
SNW.DE Yearly ROA, ROE, ROICSNW.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • SNW has a better Profit Margin (20.63%) than 78.85% of its industry peers.
  • In the last couple of years the Profit Margin of SNW has declined.
  • SNW has a Operating Margin (23.61%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of SNW has grown nicely.
  • With a Gross Margin value of 72.29%, SNW perfoms like the industry average, outperforming 51.92% of the companies in the same industry.
  • In the last couple of years the Gross Margin of SNW has remained more or less at the same level.
Industry RankSector Rank
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
SNW.DE Yearly Profit, Operating, Gross MarginsSNW.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SNW is creating some value.
  • The number of shares outstanding for SNW has been reduced compared to 1 year ago.
  • SNW has less shares outstanding than it did 5 years ago.
  • SNW has a worse debt/assets ratio than last year.
SNW.DE Yearly Shares OutstandingSNW.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
SNW.DE Yearly Total Debt VS Total AssetsSNW.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • A Debt/Equity ratio of 0.18 indicates that SNW is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.18, SNW is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC1.68
WACC7.95%
SNW.DE Yearly LT Debt VS Equity VS FCFSNW.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • SNW has a Current Ratio of 1.06. This is a normal value and indicates that SNW is financially healthy and should not expect problems in meeting its short term obligations.
  • SNW's Current ratio of 1.06 is on the low side compared to the rest of the industry. SNW is outperformed by 76.92% of its industry peers.
  • SNW has a Quick Ratio of 1.06. This is a bad value and indicates that SNW is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SNW has a Quick ratio of 0.30. This is amonst the worse of the industry: SNW underperforms 90.38% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.3
SNW.DE Yearly Current Assets VS Current LiabilitesSNW.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.82% over the past year.
  • Measured over the past 5 years, SNW shows a small growth in Earnings Per Share. The EPS has been growing by 5.58% on average per year.
  • Looking at the last year, SNW shows a small growth in Revenue. The Revenue has grown by 5.49% in the last year.
  • The Revenue has been growing slightly by 4.57% on average over the past years.
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%

3.2 Future

  • SNW is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.70% yearly.
  • SNW is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.86% yearly.
EPS Next Y8.1%
EPS Next 2Y6.92%
EPS Next 3Y8.79%
EPS Next 5Y7.7%
Revenue Next Year6.49%
Revenue Next 2Y6.66%
Revenue Next 3Y5.93%
Revenue Next 5Y4.86%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SNW.DE Yearly Revenue VS EstimatesSNW.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
SNW.DE Yearly EPS VS EstimatesSNW.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 9.94, which indicates a very decent valuation of SNW.
  • Compared to the rest of the industry, the Price/Earnings ratio of SNW indicates a rather cheap valuation: SNW is cheaper than 84.62% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of SNW to the average of the S&P500 Index (27.27), we can say SNW is valued rather cheaply.
  • The Price/Forward Earnings ratio is 9.20, which indicates a very decent valuation of SNW.
  • Based on the Price/Forward Earnings ratio, SNW is valued cheaper than 92.31% of the companies in the same industry.
  • SNW's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.16.
Industry RankSector Rank
PE 9.94
Fwd PE 9.2
SNW.DE Price Earnings VS Forward Price EarningsSNW.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SNW.DE Per share dataSNW.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • SNW has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.23
PEG (5Y)1.78
EPS Next 2Y6.92%
EPS Next 3Y8.79%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

8

5. Dividend

5.1 Amount

  • SNW has a Yearly Dividend Yield of 5.21%, which is a nice return.
  • SNW's Dividend Yield is rather good when compared to the industry average which is at 1.91. SNW pays more dividend than 90.38% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.84, SNW pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.21%

5.2 History

  • The dividend of SNW has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
SNW.DE Yearly Dividends per shareSNW.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • SNW pays out 34.36% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of SNW is growing, but earnings are growing more, so the dividend growth is sustainable.
DP34.36%
EPS Next 2Y6.92%
EPS Next 3Y8.79%
SNW.DE Yearly Income VS Free CF VS DividendSNW.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
SNW.DE Dividend Payout.SNW.DE Dividend Payout, showing the Payout Ratio.SNW.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SANOFI

FRA:SNW (2/18/2026, 7:00:00 PM)

77.74

+0.39 (+0.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners46.74%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap187.76B
Revenue(TTM)46.72B
Net Income(TTM)13.80B
Analysts77.33
Price Target100.48 (29.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.21%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.36%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.79%
Min EPS beat(2)-2.29%
Max EPS beat(2)5.86%
EPS beat(4)2
Avg EPS beat(4)1.85%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)5
Avg EPS beat(8)3.19%
EPS beat(12)7
Avg EPS beat(12)2.67%
EPS beat(16)11
Avg EPS beat(16)3.3%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)0
Avg Revenue beat(4)-1.95%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-1%
Revenue beat(12)4
Avg Revenue beat(12)9.01%
Revenue beat(16)8
Avg Revenue beat(16)21.12%
PT rev (1m)-5.63%
PT rev (3m)-5.58%
EPS NQ rev (1m)0.35%
EPS NQ rev (3m)2.34%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.58%
Revenue NQ rev (1m)1%
Revenue NQ rev (3m)1.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.64%
Valuation
Industry RankSector Rank
PE 9.94
Fwd PE 9.2
P/S 2.81
P/FCF N/A
P/OCF N/A
P/B 2.56
P/tB 42.71
EV/EBITDA N/A
EPS(TTM)7.82
EY10.06%
EPS(NY)8.45
Fwd EY10.87%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS27.7
BVpS30.33
TBVpS1.82
PEG (NY)1.23
PEG (5Y)1.78
Graham Number73.06
Profitability
Industry RankSector Rank
ROA 10.63%
ROE 18.84%
ROCE 16.17%
ROIC 13.35%
ROICexc 14.69%
ROICexgc 65.49%
OM 23.61%
PM (TTM) 20.63%
GM 72.29%
FCFM N/A
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
ROICexc(3y)8.06%
ROICexc(5y)8.26%
ROICexgc(3y)31.82%
ROICexgc(5y)35.77%
ROCE(3y)8.99%
ROCE(5y)9.04%
ROICexgc growth 3Y-8.07%
ROICexgc growth 5Y1.04%
ROICexc growth 3Y-0.36%
ROICexc growth 5Y3.93%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
F-ScoreN/A
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.3
Altman-Z N/A
F-ScoreN/A
WACC7.95%
ROIC/WACC1.68
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)127.25%
Profit Quality(5y)123.49%
High Growth Momentum
Growth
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
EPS Next Y8.1%
EPS Next 2Y6.92%
EPS Next 3Y8.79%
EPS Next 5Y7.7%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%
Revenue Next Year6.49%
Revenue Next 2Y6.66%
Revenue Next 3Y5.93%
Revenue Next 5Y4.86%
EBIT growth 1Y9.12%
EBIT growth 3Y0.11%
EBIT growth 5Y6.43%
EBIT Next Year28.46%
EBIT Next 3Y13.63%
EBIT Next 5Y7.52%
FCF growth 1Y85.47%
FCF growth 3Y9.46%
FCF growth 5Y15.4%
OCF growth 1Y20.22%
OCF growth 3Y1.22%
OCF growth 5Y8.03%

SANOFI / SNW.DE FAQ

Can you provide the ChartMill fundamental rating for SANOFI?

ChartMill assigns a fundamental rating of 5 / 10 to SNW.DE.


What is the valuation status of SANOFI (SNW.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to SANOFI (SNW.DE). This can be considered as Fairly Valued.


How profitable is SANOFI (SNW.DE) stock?

SANOFI (SNW.DE) has a profitability rating of 6 / 10.


Can you provide the financial health for SNW stock?

The financial health rating of SANOFI (SNW.DE) is 3 / 10.


What is the earnings growth outlook for SANOFI?

The Earnings per Share (EPS) of SANOFI (SNW.DE) is expected to grow by 8.1% in the next year.